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Synthesis of IAPP fragments. IAPP fragments were synthesized on a CEM Liberty 
Microwave Peptide Synthesizer using 9-fluorenylmethoxycarbonyl (FMOC) chemistry 
according to standard protocols on FMOC-Rink amide MBHA resin. Protected amino acids 
were activated with 2-(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium 
hexafluorophosphate in the presence of N,N-diisopropylethylamine in 1-methyl-2-
pyrrolidinone and the FMOC group was deprotected with piperidine. Cysteine, arginine, and 
leucine were always coupled twice. Peptides were cleaved off the resin using a cold mixture 
of 95% trifluoroacetic acid (TFA), 2.5% triisopropylsilane, and 2.5% water and subsequently 
precipitated with cold diethyl ether. The intramolecular disulfide bridge formed by subsequent 
mild oxidation or in situ by carrying out the peptide synthesis in air (high-resolution mass-
spectrometry evidence). Peptide purity was monitored by RP-HPLC using water and 
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acetonitrile gradient containing 0.1% TFA. IAPP1–14: yield 60%, purity 97.4%; IAPP2–14: 
yield 89%, purity 93.0%; IAPP1–7: yield 87%, purity 91.0%; IAPP2–7: yield 85%, purity 
90.0%. 
Disaggregation Experiment: 
ThT fluorescence assay. IAPP was prepared in phosphate buffer (PB) and aliquoted into 96-
well plates at 10-μM final concentration. Each well also contained 30 μM ThT. The final 
volume in each well was 200 μl. The reactions were incubated at 25 ºC without shaking and 
fluorescence was monitored with λex = 420 nm and λem = 485. Ten-fold CLR01 were added at 
7 h or 170 h and the reactions were monitored up to 500 h. Ten-μl aliquots of the reaction 
mixtures were removed periodically for morphological examination by EM. The data are 
presented as means ± SEM of 1–3 independent experiments with at 3–10 replicates each. 
Electron microscopy (EM). Ten μM aliquots of the reaction mixtures from the ThT 
fluorescence assay were spotted on glow-discharged, carbon-coated Formvar grids (Electron 
Microscopy Science) and stained with 1% uranyl acetate as described previously (1). The 
samples were analyzed using a JEM1200-EX (JOEL) transmission electron microscope. Fibril 
diameter and length, and oligomer diameter were measured using ImageJ (available at 
http://rsb.info.nih.gov/ij). At least 20 measurements of each parameter were performed in 
each reaction at the time points indicated. 
MTT assay. Cell viability was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction assay in rat insulinoma (RIN5fm) cells as 
described previously (2). Briefly, cells were treated for 24 h with IAPP1–37 or IAPP2–37 in the 
absence or presence of MTs and cell viability was assessed using a Promega CellTiter 96 kit. 
At least three independent experiments with six replicates (n ≥ 18) were carried out and the 
results were averaged and presented as mean ± SEM. 
NMR of IAPP fragments. Experiments examining the interaction between CLR01 and 
unlabeled IAPP fragments were carried out at 25 °C using a Bruker DRX-500 MHz 
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spectrometer equipped with a 5-mm QNP-Probe (1H) or a 5-mm TBI-Probe (1H, X, 13C) with 
Z-Gradient (gs-COSY90). 1H-NMR of CLR01 alone was measured by dissolving CLR01 at 1 
mM in 10 mM phosphate-buffered D2O, pH 7.2. Solutions of IAPP fragments in the absence 
or presence of 1 or 3 equivalents of CLR01 were prepared in 10 mM sodium phosphate in 9:1 
– H2O:D2O, pH 7.2, at peptide concentration of 1 mM in all cases. 
1H-NMR was measured 
with water suppression using presaturation and composite pulses (zgcppr). For COSY 
experiments, peptide samples were prepared in phosphate-buffered D2O, pH 7.2, in the 
absence or presence of 1 or 3 equivalents of CLR01 and gs-COSY90 (cosygpqf) spectra were 
measured. 
Fluorescence Titration. CLR01 was dissolved in 10 mM PB, pH 7.6, at 26 μM. The same 
CLR01 concentration was maintained in all IAPP solutions to keep the CLR01 concentration 
constant over the entire titration. Seven-hundred µl CLR01 were placed in a quartz cuvette of 
1-cm path length and fluorescence spectra were measured on a JASCO FP-6500 
spectrophotometer. Aliquots of peptide solution (increasing the concentration from 0.25 to 9 
eq.) were added to the tube and fluorescence spectra were recorded following each addition. 
Binding isotherms for a 1:1 complex were obtained from fluorescence emission intensities at 
336 nm and converted into binding constants by standard, non-linear regression fitting using 
Systat SigmaPlot 10.0. 
 
Supplementary Results 
CLR01 attenuates IAPP aggregation into β-sheet-rich fibrils at very low concentration 
ratios. 
Using ThT measurements, we observed lower final ThT fluorescence, and primarily 
amorphous morphology by IAPP in the presence of CLR01 concentrations as low as 1 fM, 
relative to IAPP alone (Supplementary Figure S1A). The final ThT fluorescence at 
IAPP:CLR01 concentration ratio 1:10-10 was 69±2 % that of IAPP alone. The initial CD 
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spectrum of IAPP in the presence of 1 fM CLR01 was similar to that of IAPP in the presence 
of 10 nM CLR01 and development of β-sheet was attenuated relative to IAPP incubated in the 
absence of CLR01 (Supplementary Figure S1B). The morphology of IAPP in the presence of 
1 fM CLR01 was predominantly amorphous, with occasional observation of thin, thread-like 
structures (Supplementary Figure S1C). Following 24 h of incubation, larger structures were 
observed but not amyloid fibrils. The basis for the effect of CLR01 on IAPP aggregation at 
such a low concentration (10 orders of magnitude lower concentration of CLR01 than IAPP) 
is not clear and will require additional investigation. 
 
 
Supplementary Figure S1. CLR01 attenuates IAPP aggregation and β-sheet formation at 
concentrations as low as 1 fM. A) Ten μM IAPP were incubated in the absence or presence 
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of 1 fM CLR01 at 25 ºC with constant agitation and formation of β-sheet was measured using 
the ThT fluorescence assay. The data are presented as mean ± SEM of 3 independent 
experiments. B) Ten μM IAPP were incubated in the absence or presence of CLR01 or CLR03 
at 25 ºC with constant agitation in 1-mm path length quartz cuvettes and CD spectra were 
recorded at the indicated time points. The spectra are representative of 4 independent 
experiments. C and D) Aliquots were taken at t = 0 (C) or 24 (D) h and examined by EM. The 






Time (h)  Control D1 D2 
0 
Fibril Diameter (nm) 8.7 ± 1.5   
Fibril Length (nm) 96 ± 51   
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Oligomer diameter (nm) 19 ± 5   
7 
Fibril Diameter (nm) 7.8 ± 1.4   
Fibril Length (nm) 343 ± 271   
Oligomer diameter (nm) 22 ± 5   
170 
Fibril Diameter (nm) 7.3 ± 1.3   
Fibril Length (nm) Indefinite   
294 
Fibril Diameter (nm) 8.1 ± 1.9 9.1 ± 1.8 8.6 ± 1.1 
Fibril Length (nm) Indefinite 148 ± 82 n.d. 
500 
Fibril Diameter (nm) 7.2 ± 1.4 9.0 ± 1.8 7.8 ± 1.4 
Fibril Length (nm) Indefinite 316 ± 117 157 ± 83 
 
Supplementary Figure S2. CLR01 halts IAPP aggregation. Ten μM IAPP were incubated 
in 96-well plates in the presence of 30 μM ThT without agitation at 25 ºC and monitored 
periodically for ThT fluorescence. Ten-fold excess CLR01 was added to one third of the wells 
after 7 h (D1) and to a second third of the wells after 170 h. The reactions were monitored up 
to 500 h. The data were normalized to the highest ThT fluorescence of IAPP alone and are 
presented mean ± SEM of 1–3 independent experiments with at least 3 wells per condition. 







Supplementary Figure S3. CLR01 inhibits IAPP-induced apoptosis. A) IAPP was 
incubated at 0.3 or 1 μM with RIN5fm cells for 16 h. B) IAPP was incubated at 0.3 μM in the 
absence or presence of 30 μM CLR01 with RIN5fm cells for 16 h. Apoptosis was measured 
using a commercial ELISA kit for detection of cytoplasmic histone-associated nucleosomes. 
The data are shown as mean ± SEM of 2 independent experiments. Statistical analysis was 




Supplementary Figure S4. The 1H-15N HSQC NMR signal of IAPP is stable for 12 h. 
One-hundred μM IAPP were incubated at 4 ºC and the 1H-15N HSQC NMR signal recorded at 






Supplementary Figure S5. gs-H,H-COSY NMR of 3:1 molar ratio of CLR01:IAPP1-7, 
respectively, in D2O phosphate buffer. K1 side chain protons in the complex are assigned as 
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Supplementary Figure S7. 1H-NMR spectra of 1.0 mM IAPP2–7, 3.0 mM CLR01, and a 1:3 
mixture of the two in 10 mM sodium phosphate, pH 7.2. No interaction is seen between 




Supplementary Figure S8. 1H-NMR spectra of 1.0 mM IAPP1–14, 3.0 mM CLR01, and a 1:3 
mixture of the two in 10 mM sodium phosphate, pH 7.2. CLR01 is involved in complex 
formation with both, K1 and R11 (K1 signals marked in black, R11 signals in red). 
Complexed K1 signals show almost the same upfield shift as in the complex with IAPP1-7. By 
contrast, R11 signals are broadened and significantly less upfield-shifted than in the complex 





Supplementary Figure S9. gs-H,H-COSY NMR of 3:1 molar ratio of CLR01:IAPP2–14, 
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Supplementary Figure S10. Mean smallest distance between residues (contact map) and 
representative structure of the most populated cluster. A) IAPP2-37, and B) IAPP2-37CLR01R11 
 
 
Supplementary Figure S11. Initial geometries of IAPP1-37 in A) IAPP1-37
α64%  (System I), B) 
IAPP
1-37




Supplementary Table S1. Cluster population analysis: Percent of compact and extended 
structures 
 Kinked Extended 
IAPP1-37 4 96 
IAPP1-37CLR01K1 100 0 
IAPP1-37CLR01R11 95 5 
IAPP1-37CLR01K1+R11 100 0 
   
IAPP2-37   
 
89 11 





Supplementary Table S2. Selected geometrical parameters illustrating the inclusion of K1 
(left structure) or R11 (right structure) side chains inside the tweezer’s cavity. The Cp – Cp and 
Cm – Cm distances (Å, dotted red lines) indicate the deformation of the tweezers upon 
inclusion of the amino acids in the cavity. The distance N/C – P (Å) and the corresponding 
angle (degrees, dotted green lines) indicate how deep the side chains are inside the tweezer 
cavity. In the case of R11, C is the central carbon atom of the guanidinium moiety. 
 
 Cp – Cp Cm – Cm N(C)
b – P Angle 
Crystal Structurea 5.89 4.20 3.89 90.8 
System I 
IAPP1-37CLR01K1 5.59 ± 0.53 4.09 ± 0.55 3.95 ± 0.14 85.9 ± 6.4 
IAPP1-37CLR01R11 5.80 ± 0.39 4.10 ± 0.42 4.90 ± 0.69 81.6 ± 12.2 
IAPP1-37CLR01K1+R11 
(5.81 ± 0.51)K1 (4.36 ± 0.58)K1 (4.17 ± 0.63)K1 (90.1 ± 8.1)K1 
(6.37± 0.65)R11 (5.06 ± 0.87)R11 (4.70 ± 0.48)R11 (73.9 ± 11.3)R11 
IAPP2-37CLR01R11 5.90 ± 0.37 4.33 ± 0.45 4.61 ± 0.54 77.0 ± 10.9 
 System II   
IAPP1-37CLR01K1 5.61 ± 0.46 4.15 ± 0.43 3.97 ± 0.26 87.87 ± 7.68 
(a) Crystal structure values of CLR01 complexed with K in a 14-3-3 protein (3). 





Supplementary Table S3: Secondary structure content for selected conformations of IAPP1-
37 (at t = 0 and t = 10 ns) and averaged over the REMD simulations of IAPP1-37 and IAPP1-37 
CLR01K1 in System II. 
  Helix Coil Turn 3-10-helix 
System II IAPP1-37 (t = 0) 27.02 32.43 21.62 18.91 
IAPP1-37 (t = 10 ns) 45.94 35.13 10.81 8.1 
IAPP1-37  63.23 26.11 10.33 0.33 
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